We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
No events to show.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
CSCI SEC Filings - Cosciens Biopharma 10-K, 10-Q, 8-K Forms - Stock Titan
CSCI SEC Filings - Cosciens Biopharma 10-K, 10-Q, 8-K Forms Stock Titan
June 17 shareholder meeting set by COSCIENS Biopharma (CSCI) - Stock Titan
June 17 shareholder meeting set by COSCIENS Biopharma (CSCI) Stock Titan
COSCIENS Biopharma: Q1 Earnings Snapshot - KTVB
COSCIENS Biopharma: Q1 Earnings Snapshot KTVB
COSCIENS Biopharma Inc. Reports Q1 2026 Results
COSCIENS Biopharma Inc. Reports Q1 2026 Results - GlobeNewswire
COSCIENS Biopharma Inc. Reports Q1 2026 Results GlobeNewswire
COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 12. | After market close (AMC) | — | — | — | — | — | Scheduled |
No research actions to show.
Price data
No holdings data to show.